Skip to main content
. 2020 Oct 8;3(10):e2019861. doi: 10.1001/jamanetworkopen.2020.19861

Figure 2. Cost-effectiveness Acceptability Curve for Metacarpophalangeal (MCP) Joint Contractures.

Figure 2.

At a willingness-to-pay threshold of $100 000 per quality-adjusted life-year (QALY), 3 percutaneous needle aponeurotomy (PNA) treatments (PNA-PNA-PNA) had a 44% and 15% chance of being the most cost-effective treatment combination compared with the remaining 26 treatment sequences in low-severity and high-severity MCP joint contractures, respectively. CCH indicates collagenase clostridium histolyticum injection; and LF, limited fasciectomy.

HHS Vulnerability Disclosure